Skip to main content
  • Herceptin Tied to Heart Issues in Breast Ca Patients

    Adherence to cardiac monitoring less than ideal in trastuzumab recipients

    Drug-related cardiotoxicity leading to incident cases of heart failure after a breast cancer diagnosis occurred even with so-called targeted therapies, according to a retrospective study.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details